Tag: follow-on biologics

US Drug Prices Much Higher Than in Other Nations

Prescription drug prices in the United States are more than 250% times higher overall than those in 32 other countries, according to a new report...

Ranibizumab Biosimilar Shows Equivalent Efficacy to Branded Drug for Neovascular AMD

NEW YORK (Reuters Health) – In a phase 3 study, the ranibizumab biosimilar SB11 demonstrated equivalent efficacy and similar safety and immunogenicity profiles compared with...

EU Plans Easier Access to Generics in Potential Blow to Big Drugmakers

BRUSSELS (Reuters) – The European Commission wants to make it easier for patients to access cheaper, generic medicines, a draft EU document seen by Reuters...